Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma: a Pilot Study.

NCT05340569 is registered in ClinicalTrials.gov with Laval University as lead sponsor.

NCT NCT05340569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05340569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma: a Pilot Study.
Lead sponsor
Laval University
Phase
Not applicable
Overall status
Completed
Start date
March 28, 2022
Completion date
September 30, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas adenocarcinoma, pancreas cancer, duct cell adenocarcinoma, peritoneal carcinomatosis, peritoneal metastases